Canadian cannabis company Canopy Growth has named Judy Hong as vice president of investor relations. Her appointment becomes effective December 2, 2019. Prior to joining Canopy Growth, Hong worked at Goldman Sachs where she most recently served as managing director of its global investment research division.
SMITHS FALLS, ON, Nov. 26, 2019 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”), is pleased to announce the appointment of Judy Hong as Vice President, Investor Relations, effective December 2, 2019. In her role, Judy will partner with Tyler Burns and lead the strategic planning, direction and execution of the Company’s investor relations function, further developing and strengthening its global investor relations program.
Judy has over 20 years of experience at Goldman Sachs & Co (“Goldman Sachs”), most recently serving as a Managing Director of its Global Investment Research Division covering the US beverage and tobacco sectors. She has covered many of the world’s most prominent consumer product goods companies during her tenure at Goldman Sachs, and the consistently high quality of her work has been recognized by numerous industry surveys and publications including Institutional Investor, Fortune, Forbes and the Wall Street Journal. Judy will be based in New York City and will report directly to Executive Vice President & Chief Financial Officer Mike Lee.
“We are very pleased to have a capital markets professional with Judy’s experience join our investor relations team,” said Mike Lee, Executive Vice President and Chief Financial Officer. “We believe Judy’s extensive knowledge of the consumer products goods sector, along with her credibility among key institutional investors, will help Canopy expand and strengthen our capital markets presence on the ground in New York City.”
“Having achieved significant success over two decades in equity research, the time is right for me to tackle a new challenge,” said Judy Hong. “I am excited to be joining Canopy during a time of great change and opportunity in the cannabis industry. I look forward to playing a critical role in shaping and communicating Canopy’s story to the U.S. and global investment community.”
Judy holds an MBA in Finance from the NYU Stern School of Business and a Bachelor of Science in Communications from Cornell University.
About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com